These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6707905)

  • 41. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of low-dose 15-methyl prostaglandins F2 alpha for cervical ripening in the first trimester of pregnancy.
    Romem Y
    Am J Obstet Gynecol; 1984 Nov; 150(6):798-9. PubMed ID: 6496609
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of 15-methyl prostaglandin F2 alpha on isolated smooth muscles of the guinea pig].
    Wei X; Si NC; Luo AC; Yang ZC
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):125-7. PubMed ID: 2946147
    [No Abstract]   [Full Text] [Related]  

  • 44. Uterine rupture due to 15-methylprostaglandin F2 alpha.
    Vergote I; Oeyen L; De Schrijver D; Uyttenbroeck F
    Lancet; 1982 Dec; 2(8312):1402. PubMed ID: 6129492
    [No Abstract]   [Full Text] [Related]  

  • 45. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
    Borten M; Friedman EA
    J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol.
    Perry KG; Rinehart BK; Terrone DA; Martin RW; May WL; Roberts WE
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1057-61. PubMed ID: 10561618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976).
    Southern EM
    Prostaglandins; 1976; 12 Suppl():147-52. PubMed ID: 788056
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug release testing of a prostaglandin containing controlled-release vaginal device: development of a semi-automated method.
    Halstead GW; Theis DL
    J Pharm Sci; 1985 Oct; 74(10):1086-90. PubMed ID: 4078708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local administration of (15 S)-15-methyl PGF2 alpha for management of hypotonic post-partum hemorrhage.
    Thiery M; Parewijck W
    Z Geburtshilfe Perinatol; 1985; 189(4):179-80. PubMed ID: 3876658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of persistent vesical bleeding due to radiation cystitis by intravesical application of 15 (S) 15-methyl prostaglandin F2-alpha.
    Hemal AK; Praveen BV; Sankaranarayanan A; Vaidyanathan S
    Indian J Cancer; 1989 Jun; 26(2):99-101. PubMed ID: 2592003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnancy interception with a combination of prostaglandins: studies in monkeys.
    Wilks JW
    Science; 1983 Sep; 221(4618):1407-9. PubMed ID: 6612350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue.
    Hayashi RH; Castillo MS; Noah ML
    Obstet Gynecol; 1984 Jun; 63(6):806-8. PubMed ID: 6610143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detrusor supersensitivity to 15 (S) 15-methyl prostaglandin F2-alpha in chronic neurogenic vesical dysfunction.
    Vaidyanathan S; Rao MS; Mapa MK; Rao K; Sharma PL; Chary KS
    Indian J Med Res; 1982 Jun; 75():839-45. PubMed ID: 7129556
    [No Abstract]   [Full Text] [Related]  

  • 54. Uterine rupture following intramuscular injection of Carboprost in midtrimester pregnancy termination.
    Tripathy SN
    J Indian Med Assoc; 1985 Sep; 83(9):328. PubMed ID: 4086862
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antiserum reaction to prostaglandin F2 alpha with modified prostaglandins F2].
    Bezuglov VV; Gromova NV; Bassalyk LS; Shevchenko VP; Miasoedov NF
    Dokl Akad Nauk SSSR; 1980; 255(4):999-1002. PubMed ID: 7215136
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic changes induced by 15(S) 15-methyl prostaglandin F2 alpha in tumoral cells.
    Caminiti F; De Murtas M; Parodo G; Lecca U; Marongiu ME; La Colla P; Nasi A
    Eur J Gynaecol Oncol; 1980 May; 1(2):112-5. PubMed ID: 6949763
    [No Abstract]   [Full Text] [Related]  

  • 57. [Characteristics of placental permeability for 9-H3-prostaglandin F2 alpha at different periods of pregnancy].
    Kiriushchenkov AP; Sheveleva GA; Pugacheva TN; Eleni EL
    Akush Ginekol (Mosk); 1979 Aug; (8):31-4. PubMed ID: 532884
    [No Abstract]   [Full Text] [Related]  

  • 58. Metabolism of prostaglandins, prostaglandin analogs and thromboxane B2 by lung and liver microsomes from pregnant rabbits.
    Powell WS
    Biochim Biophys Acta; 1979 Dec; 575(3):335-49. PubMed ID: 518891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption and penetration of dinoprost (prostaglandin F2 alpha) and dinoprost methyl ester into perfused mesenteric circulation in rats.
    Taylor BM; Sun FF
    J Pharm Sci; 1979 Aug; 68(8):983-6. PubMed ID: 480179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Induction for termination of pregnancy in the second trimester and for delivery of babies dead in utero using intramuscular injections of 15-methyl-PGF2 alpha (author's transl)].
    Kunz B; De Grandi P
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(4):375-84. PubMed ID: 7299101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.